AGENUS INC Payments of Debt Issuance Costs
AGENUS INC (AGEN) reported Payments of Debt Issuance Costs of $150.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2020-03-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDebtIssuanceCosts · last filed 2020-03-16
- AGENUS INC payments of debt issuance costs for the quarter ending 2015-12-31 was $0.00.
- AGENUS INC payments of debt issuance costs for fiscal 2017 was $150.00K.
- AGENUS INC payments of debt issuance costs for fiscal 2015 was $1.77M.
- AGENUS INC payments of debt issuance costs for fiscal 2013 was $177.80K.
| Period end | Payments of Debt Issuance Costs 3 month | Payments of Debt Issuance Costs 9 month | Payments of Debt Issuance Costs 12 month |
|---|---|---|---|
| 2017-12-31 | $150.00K 10-K · filed 2020-03-16 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-16 | $1.77M 10-K · filed 2018-03-16 | |
| 2015-09-30 | $1.77M 10-Q · filed 2016-11-09 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-04 | ||
| 2013-12-31 | $177.80K 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |